dobutamine has been researched along with Cardio-Renal Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L | 1 |
| Diskin, CJ; Diskin, JB; Oberle, MD; Walker, CB | 1 |
| Andersson, B; Bartfay, SE; Bergh, N; Bollano, E; Dahlberg, P; Gilljam, T; Hjalmarsson, C; Karason, K; Lannemyr, L; Ljungman, C; Ricksten, SE; Rundqvist, B | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
1 review(s) available for dobutamine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
1 trial(s) available for dobutamine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
Topics: Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamic Monitoring; Hemodynamics; Humans; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Renal Insufficiency; Renal Plasma Flow; Simendan | 2018 |
2 other study(ies) available for dobutamine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan | 2017 |
Use of the Fractional Excretion of Urea in an Azotemic Nonoliguric State: Type 1 Cardiorenal Syndrome.
Topics: Aged; Aged, 80 and over; Azotemia; Blood Urea Nitrogen; Cardio-Renal Syndrome; Cardiotonic Agents; Creatinine; Dobutamine; Female; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Sodium; Survival; Urea | 2018 |